Lex

Abbvie/Pharmacyclics - pay to play

US-based pharmaceuticals company AbbVie has agreed to acquire Pharmacyclics for $21bn. Lex’s Robert Armstrong and Rochelle Toplensky discuss the deal and the rising cost of doing business for Big Pharma.